CCR1 and Miyoshi myopathy: The binding of CCL-3 to its G-protein coupled receptors, CCR1 and CCR5, activates the ERK and AKT signaling pathways and contributes to the development of bone disease in MM by supporting tumor growth and regulating osteoclast differentiation [26,27].